T1D, Metabolic Syndrome and Insulin Resistance

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

February 15, 2022

Study Completion Date

March 1, 2022

Conditions
Type 1 DiabetesMetabolic SyndromeInsulin Resistance
Trial Locations (1)

86090

Isela Esther Juarez Rojop, Villahermosa

All Listed Sponsors
lead

Universidad Juárez Autónoma de Tabasco

OTHER

NCT05503303 - T1D, Metabolic Syndrome and Insulin Resistance | Biotech Hunter | Biotech Hunter